Table 3 Specificity and sensitivity of the detection of treatment failure based on cfHPV DNA assessment exclusively
cfHPV16 DNA | Treatment failure (residual or metastatic disease) No of individuals | ||
|---|---|---|---|
Residual or metastatic disease | Cured | Total | |
Positive | 5a | 1b | 6 (PPV, 83%) |
Negative | 0 | 60 | 60 (NPV, 100%) |
Total | 5 (sensitivity, 100%) | 61 (specificity, 98%) | 66 |